Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure

M. N Sinkova; L. K Isakov; T. V Pepelyaeva; N. I Tarasov; A. T Teplyakov; F. Yu Mukharlyamov

КардиоСоматика (Jun 2015)

Impact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure

M. N Sinkova,
L. K Isakov,
T. V Pepelyaeva,
N. I Tarasov,
A. T Teplyakov,
F. Yu Mukharlyamov

Affiliations

M. N Sinkova: Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation
L. K Isakov: Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation
T. V Pepelyaeva: Heath part RF MIA Kemerovo region
N. I Tarasov: Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation
A. T Teplyakov: State Organization Institute of Cardiology
F. Yu Mukharlyamov: Moscow Centre for Research and Practice in Medical Rehabilitation, Restorative and Sports Medicine of Moscow Healthcare Department

Journal volume & issue: Vol. 6, no. 2
pp. 30 – 34

Abstract

Read online

The article analyzes the effectiveness and safety of treatment cytoprotectant meldonium dihydrate and inotropic stimulator of levosimendan on an annual prognosis in patients with myocardial infarction complicated by acute heart failure II-III class Killip, subjected to percutaneous transluminal coronary angioplasty.

Published in КардиоСоматика

ISSN: 2221-7185 (Print); 2658-5707 (Online)
Publisher: Concilium Medicum
Country of publisher: Russian Federation
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system; Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://cardiosomatics.orscience.ru/

About the journal

Abstract

Keywords